| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 18.408 | 103.552 | 67.847 | 32.241 |
| Total Income - EUR | - | - | - | - | - | - | 20.362 | 102.000 | 67.732 | 35.507 |
| Total Expenses - EUR | - | - | - | - | - | - | 26.977 | 92.651 | 66.264 | 56.780 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -6.615 | 9.349 | 1.468 | -21.273 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -6.799 | 8.334 | 790 | -22.279 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Angidav-Cris S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 55 | 1.813 | 1.795 | 17 |
| Current Assets | - | - | - | - | - | - | 2.296 | 3.147 | 20.184 | 13.851 |
| Inventories | - | - | - | - | - | - | 2.242 | 1.393 | 9.319 | 9.043 |
| Receivables | - | - | - | - | - | - | 28 | 341 | 268 | 15 |
| Cash | - | - | - | - | - | - | 25 | 1.413 | 10.597 | 4.793 |
| Shareholders Funds | - | - | - | - | - | - | -6.759 | 1.555 | 2.340 | -19.953 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 9.109 | 3.405 | 19.640 | 33.821 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1610 - 1610" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Angidav-Cris S.r.l.